Disparities are endemic across our healthcare system. Novartis and the Novartis US Foundation have taken a major step forward to address the root causes of disparities in health and education by launching Beacon of Hope, an innovative ten-year collaboration with 26 Historically Black Colleges and Universities (HBCUs), including four HBCU Medical Schools, Merck, Sanofi, the National Medical Association, Thurgood Marshall College Fund, and Coursera.

Measurable Solutions For Health Equity

The goal of the Beacon of Hope initiative is to co-create effective, measurable solutions for health equity, focusing in three key areas:

Media Release

Novartis expands Beacon of Hope through alliances with Historically Black Medical Schools to address systemic health disparities

Read More

matchaba patrice 550x550 portrait image_0

Addressing Health Inequities Starts By Looking Within

Read about the significance of Beacon of Hope from Patrice Matchaba, M.D., Head, US Corporate Responsibility and President, Novartis US Foundation in this interview.

Clinical trials pledge signatures

Beacon of Hope Pledge

Stakeholders who signed the original Beacon of Hope Pledge committed to collaboration in finding solutions to addressing systemic disparities in education and health outcomes to create greater diversity, equity and inclusion across the research and development ecosystem.